These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 19086612
1. Management algorithms for stage IIIA non-small cell lung cancer with N2 node involvement. Detterbeck F, Sukumar MS. Thorac Surg Clin; 2008 Nov; 18(4):437-41, vii. PubMed ID: 19086612 [Abstract] [Full Text] [Related]
2. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer. Garland L, Robinson LA, Wagner H. Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602 [Abstract] [Full Text] [Related]
3. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival. Decaluwé H, De Leyn P, Vansteenkiste J, Dooms C, Van Raemdonck D, Nafteux P, Coosemans W, Lerut T. Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079 [Abstract] [Full Text] [Related]
4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ. Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112 [Abstract] [Full Text] [Related]
5. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer. Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Eur J Cardiothorac Surg; 2008 Jul 01; 34(1):187-95. PubMed ID: 18457958 [Abstract] [Full Text] [Related]
6. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer. Leo F, De Pas T, Catalano G, Piperno G, Curigliano G, Solli P, Veronesi G, Petrella F, Spaggiari L. J Natl Cancer Inst; 2007 Aug 01; 99(15):1210; author reply 1210-1. PubMed ID: 17652281 [No Abstract] [Full Text] [Related]
7. Intraoperative staging and surgical management of stage IIIA/N2 non-small cell lung cancer. Brichkov I, Keller SM. Thorac Surg Clin; 2008 Nov 01; 18(4):381-91. PubMed ID: 19086607 [Abstract] [Full Text] [Related]
13. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH, Eastern Cooperative Oncology Group. J Thorac Cardiovasc Surg; 2004 Jul 01; 128(1):130-7. PubMed ID: 15224032 [Abstract] [Full Text] [Related]
14. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941? Van Meerbeeck JP, De Pauw R, Tournoy K. Expert Rev Anticancer Ther; 2008 Feb 01; 8(2):199-206. PubMed ID: 18279061 [Abstract] [Full Text] [Related]
20. Induction therapy in non-small-cell lung cancer: a comparison of clinical and post-surgical staging. Granone PL, Margaritora S, Cesario A, Galetta D. Ann Ital Chir; 1999 Feb 01; 70(6):899-903. PubMed ID: 10804669 [Abstract] [Full Text] [Related] Page: [Next] [New Search]